Literature DB >> 11309695

Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells.

J W Gratama1, D R Sutherland, M Keeney.   

Abstract

Flow cytometric enumeration of CD34(+) hematopoietic stem and progenitor cells (HPC) is widely used to evaluate the adequacy of peripheral blood stem cell grafts and is also useful for planning the apheresis sessions needed to obtain these grafts. A state-of-the-art method to enumerate CD34(+) cells has been developed that makes use of a multiparameter definition of HPC, based on their light scatter characteristics and dim expression of CD45, utilizing fluorescent counting beads. This approach allows the absolute CD34(+) cell count to be determined directly from a flow cytometer. The method can be extended with a viability stain and additional markers for further immunologic characterization of CD34(+) cells, and has been successfully implemented in multicenter trials. Using such a standardized assay, it should be possible to define more accurately the lower threshold for a safe HPC graft in terms of short- and long-term hematopoietic reconstitution. Semin Hematol 38:139-147. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Year:  2001        PMID: 11309695     DOI: 10.1016/s0037-1963(01)90047-2

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  5 in total

1.  Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors.

Authors:  D-F Chen; V K Prasad; G Broadwater; N L Reinsmoen; A DeOliveira; A Clark; K M Sullivan; J P Chute; M E Horwitz; C Gasparetto; G D Long; Y Yang; N J Chao; D A Rizzieri
Journal:  Bone Marrow Transplant       Date:  2011-12-05       Impact factor: 5.483

2.  Stimulus-triggered fate conversion of somatic cells into pluripotency.

Authors:  Haruko Obokata; Teruhiko Wakayama; Yoshiki Sasai; Koji Kojima; Martin P Vacanti; Hitoshi Niwa; Masayuki Yamato; Charles A Vacanti
Journal:  Nature       Date:  2014-01-30       Impact factor: 49.962

3.  Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol.

Authors:  Caroline Schmidt-Lucke; Stephan Fichtlscherer; Alexandra Aicher; Carsten Tschöpe; Heinz-Peter Schultheiss; Andreas M Zeiher; Stefanie Dimmeler
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

4.  Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD).

Authors:  Girum Mekonnen; Salim S Hayek; Puja K Mehta; Qunna Li; Ernestine Mahar; Liping Mou; Tanya S Kenkre; John W Petersen; Babak Azarbal; Bruce Samuels; R David Anderson; Tara Sedlak; Melody Zaya; Megha Agarwal; Afsaneh Haftbaradaran; Margo Minissian; Eileen Handberg; Carl J Pepine; Christopher R Cogle; C Noel Bairey Merz; Edmund K Waller; Arshed A Quyyumi
Journal:  Atherosclerosis       Date:  2016-08-26       Impact factor: 6.847

5.  Autologous Peripheral Blood Stem Cell Transplantation Among Lymphoproliferative Disease Patients: Factors Influencing Engraftment.

Authors:  Mohd Nazri Hassan; Hafizuddin Mohamed Fauzi; Azlan Husin; Rapiaah Mustaffa; Rosline Hassan; Mohd Ismail Ibrahim; Noor Haslina Mohd Noor
Journal:  Oman Med J       Date:  2019-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.